Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET) / carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma

Modern Pathology

Volumn 11, Issue 10, 1998, Pages 989-994

  Dorfman, David M ^a   Shahsafaei, Aliakbar ^a   Miyauchi, Akira ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b KUMA HOSPITAL   (Japan)

Author keywords

Bcl 2; CD5; Immunohistochemistry; Mcl 1; Thymus; Thyroid

Indexed keywords

CD5 ANTIGEN; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ECTOPIC TISSUE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; NECK; PRIORITY JOURNAL; PROTO ONCOGENE; THYMOMA; THYMUS CANCER; THYROID GLAND; TUMOR DIFFERENTIATION;

ADULT; AGED; ANTIGENS, CD5; CELL DIFFERENTIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; THYMOMA; THYMUS NEOPLASMS; THYROID NEOPLASMS;

EID: 0031790966     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Chan JKC, Rosai J. Tumors of the neck showing thymic or related branchial pouch differentiation: a unifying concept. Hum Pathol 1991;22:349-67.
2. Miyauchi A, Kuma K, Matsuzuka F, Matsubayashi S, Kobayashi A, Tamai H, et al. Intrathyroidal epithelial thymoma: an entity distinct from squamous cells carcinoma of the thyroid. World J Surg 1985;9:128-35.
3. Miyauchi A, Ishikawa H, Maeda M, Kuma K, Matsuzuka F, Hirai K, et al. Intrathyroidal epithelial thymoma: a report of six cases with immunohistochemical and ultrastructural studies. Endocr Surg 1989;6:289-95.
4. Kakudo K, Mori I, Tamaoki N, Watanabe K. Carcinoma of possible thymic origin presenting as a thyroid mass: a new subgroup of squamous cell carcinoma of the thyroid. J Surg Oncol 1988;138:187-92.
5. Damiani S, Filotico M, Eusebi V. Carcinoma of the thyroid showing thymus-like features. Virchows Arch A Pathol Anat Histopathol 1991;418:463-6.
6. Berezowski K, Grimes MM, Gal A, Kornstein MJ. CD5 immunoreactivity of epithelial cells in thymic carcinoma and CASTLE using paraffin-embedded tissue. Am J Clin Pathol 1996; 106:483-6.
7. Dorfman DM, Shahsafaei A, Miyauchi A. Intrathyroidal epithelial thymoma (ITET) / carcinoma showing thymus-like differentiation (CASTLE) exhibits CD5 immunoreactivity: new evidence for thymic differentiation. Histopathology 1998;32:104-9.
8. Krajewski S, Bodrug S, Krajewska M, Shabaik A, Gascoyne R, Berean K, et al. Immunohistochemical analysis of mcl-1 protein in human tissues: differential regulation of mcl-1 and bcl-2 protein production suggests a unique role for mcl-1 in control of programmed cell death in vivo. Am J Pathol 1995;146:1309-19.
9. Chen F-F, Van J-J, Jin Y-T, Su I-J. Detection of bcl-2 and p53 in thymoma: expression of bcl-2 as a reliable marker of tumor aggressiveness. Hum Pathol 1996;27:1089-92.
10. Stefanaki K, Rontogianni D, Kouvidou CH, Bolioti S, Delides G, Pantelidaki A, et al. Expression of p53, mdm2, p21/waf1, and bcl-2 proteins in thymomas. Histopathology 1997;30: 549-55.
11. Tateyama H, Eimoto T, Tada T, Inagaki H, Hattori H, Takino H. Apoptosis, bcl-2 protein, and fas antigen in thymic epithelial tumors. Mod Pathol 1997;10:983-91.
12. Chen F-F, Van J-J, Chang K-C, Lai W-W, Chien RM-Y, Jin Y-T. Immunohistochemical localization of mcl-1 and bcl-2 proteins in thymic epithelial tumors. Histopathology 1996;29: 541-7.
13. MIC2) immunoreactivity in the diagnosis of thymic neoplasms and mediastinal lymphoproliferative disorders: a study of paraffin sections using monoclonal antibody O13. Appl Immunohistochem 1996;4:34-42.
14. Dorfman DM, Shahsafaei A, Chan JKC. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity. Am J Surg Pathol 1997;21:936-40.
15. Rosai J. Ackerman's surgical pathology. 8th ed. St. Louis: Mosby; 1996. p. 442-58.
16. Nomori H, Morinaga S, Kobayashi R, Mimura T. Cervical thymic cancer infiltrating the trachea and thyroid. Eur J Cardiothorac Surg 1994;8:222-4.
17. Juarbe C, Conley JJ, Gillooley JF, Angel MF. Metastatic cervical thymoma. Otolaryngol Head Neck Surg 1989;100: 232-6.
18. Martin JME, Randhawa G, Temple WJ. Cervical thymoma. Arch Pathol Lab Med 1986;110:354-7.
19. Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC. Immunohistochemical analysis of mcl-1 and bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 1994;145:515-25.
20. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, et al. bcl-2 protein in non-small cell lung carcinoma. N Engl J Med 1993;329:690-4.
21. Vargas MP, Vargas HI, Kleiner DE, Merino MJ. The role of prognostic markers (MIB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors. Mod Pathol 1997;10:12-7.
22. Krajewski S, Krajewska M, Ehrmann J, Sikorska M, Lach B, Chatten J, et al. Immunohistochemical analysis of bcl-2, bcl-X, mcl-1, and Bax in tumors of central and peripheral nervous system origin. Am J Pathol 1997;150:805-14.
23. Wehrli BM, Krajewski S, Gascoyne R, Reed JC, Gilks CB. Immunohistochemical analysis of bcl-2, Bax, mcl-1, and bcl-X expression in ovarian surface epithelial tumors [abstract]. Mod Pathol 1998;11:116A.
24. Krajewska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot J, Song K, et al. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol 1996;148:1567-76.